Themis Medicare Limited - Asset Resilience Ratio

Latest as of September 2025: 2.65%

Themis Medicare Limited (THEMISMED) has an Asset Resilience Ratio of 2.65% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Themis Medicare Limited for a breakdown of total debt and financial obligations.

Liquid Assets

Rs154.37 Million
≈ $1.67 Million USD Cash + Short-term Investments

Total Assets

Rs5.82 Billion
≈ $62.99 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Themis Medicare Limited's Asset Resilience Ratio has changed over time. See Themis Medicare Limited (THEMISMED) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Themis Medicare Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Themis Medicare Limited.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs46.12 Million 0.79%
Short-term Investments Rs108.25 Million 1.86%
Total Liquid Assets Rs154.37 Million 2.65%

Asset Resilience Insights

  • Limited Liquidity: Themis Medicare Limited maintains only 2.65% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Themis Medicare Limited Industry Peers by Asset Resilience Ratio

Compare Themis Medicare Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 9.09%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.02%
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
Drug Manufacturers - Specialty & Generic 0.01%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%

Annual Asset Resilience Ratio for Themis Medicare Limited (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Themis Medicare Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 1.07% Rs62.81 Million
≈ $679.22K
Rs5.88 Billion
≈ $63.59 Million
+1.07pp
2024-03-31 0.00% Rs33.00K
≈ $356.88
Rs5.66 Billion
≈ $61.26 Million
-3.42pp
2023-03-31 3.42% Rs176.01 Million
≈ $1.90 Million
Rs5.14 Billion
≈ $55.58 Million
+0.82pp
2022-03-31 2.61% Rs111.62 Million
≈ $1.21 Million
Rs4.28 Billion
≈ $46.26 Million
+2.61pp
2021-03-31 0.00% Rs33.00K
≈ $356.88
Rs3.71 Billion
≈ $40.14 Million
0.00pp
2020-03-31 0.00% Rs33.00K
≈ $356.88
Rs3.50 Billion
≈ $37.84 Million
-1.24pp
2019-03-31 1.24% Rs39.04 Million
≈ $422.24K
Rs3.14 Billion
≈ $33.97 Million
+0.01pp
2018-03-31 1.24% Rs37.72 Million
≈ $407.96K
Rs3.05 Billion
≈ $33.01 Million
+0.90pp
2017-03-31 0.34% Rs10.55 Million
≈ $114.08K
Rs3.10 Billion
≈ $33.50 Million
+0.59pp
2016-03-31 -0.25% Rs-7.00 Million
≈ $-75.65K
Rs2.76 Billion
≈ $29.86 Million
-0.16pp
2015-03-31 -0.09% Rs-2.62 Million
≈ $-28.35K
Rs2.79 Billion
≈ $30.21 Million
0.00pp
2014-03-31 -0.09% Rs-2.62 Million
≈ $-28.29K
Rs2.85 Billion
≈ $30.81 Million
+0.00pp
2013-03-31 -0.10% Rs-2.61 Million
≈ $-28.18K
Rs2.73 Billion
≈ $29.57 Million
-6.87pp
2006-03-31 6.77% Rs106.63 Million
≈ $1.15 Million
Rs1.57 Billion
≈ $17.02 Million
--
pp = percentage points

About Themis Medicare Limited

NSE:THEMISMED India Drug Manufacturers - Specialty & Generic
Market Cap
$98.31 Million
Rs9.09 Billion INR
Market Cap Rank
#19249 Global
#1028 in India
Share Price
Rs98.70
Change (1 day)
+5.26%
52-Week Range
Rs66.07 - Rs170.74
All Time High
Rs300.15
About

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including anti-tuberculosis, analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic,… Read more